Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Ovarian Cancer treatment details. Biologic therapy. University Hospital of Gieben and Marburg, Marburg, Germany



Survival: 13.7 months
   
Toxicity Grade: 4
   
Treatments: Biologic therapy
   
Drugs:
Country: Germany
   
City/State/Province: Marburg
   
Hospital: University Hospital of Gieben and Marburg
   
Journal: Link
   
Date: 9/2012

Description:
Patients:
This phase 2 study involved 37 ovarian cancer patients who had recurrence of their cancer following previous platinum-based chemotherapy. The average patient age was 58.5 years.

Treatment:
Patients were treated with the biologic therapy agent sunitinib, which is a tyrosine kinase inhibitor that causes an inhibition of tumor growth.

Toxicities:
The most severe toxicities were of grade 4. Grade 3-4 toxicities included thrombocytopenia, neutropenia, and leukopenia.

Results:
The median overall survival was 13.7 months.

Support:
This study was supported by Pfizer.

Correspondence: Dr. K. H. Baumann; email: baumannk@med.uni-marburg.de

E-mail to a Friend Email Physician More Information